Author Details

Boutayeb, S., National Institute of Oncology, Morocco

  • Vol 23, No 2 (2016) - Letter to the Editor
    Second-line treatment of non-small-cell lung cancer with wild-type EGFR status. What is the best approach?
    Abstract  PDF  HTML